Nolan Sean P.
- SEC CIK
- 0001569926
In the past year, 1 open-market sale filing worth $840.2K and no purchases.
Current role at each company
- VTR Ventas, Inc.Directoras of May 15, 2026
- TSHA Taysha Gene Therapies, Inc.Chief Executive Officeras of Jan 27, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $840.2K
- 1 filing
- Net
- −$840.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Nolan Sean P. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TSHA Taysha Gene Therapies, Inc.
Chief Executive Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 27, 2026 (view filing) | Jan 23-26 | 4 days | Nolan Sean P.Chief Executive Officer | SSale | −178.1K | $4.72 | −$840.2K | −5.8%2.91M after | 2 lots |
| Aug 16, 2023 (view filing) | Aug 16 | Same day | Nolan Sean P.Chief Executive Officer | PPurchase | +444.4K | $0.90 | +$400.0K | +40.7%1.54M after |